ARTICLE
|
doi:10.20944/preprints202212.0442.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
P21; CDKN1A; glioblastoma; senescence; cancer senescence; gene overexpression; gene knock-in; CRISPR/Cas9; dCas; dCas-VPR
Online: 23 December 2022 (04:10:22 CET)